Lawrence (Larry) Marnett

February 9, 2017

Forum highlights research achievements

Communication and collaboration were major themes of the inaugural Research Enterprise Forum sponsored jointly by Vanderbilt University Medical Center (VUMC) and Vanderbilt University School of Medicine (VUSM) Feb. 3 in Light Hall.

January 19, 2017

COX-2 ‘conjugate’ may slow growth of some tumors: study

More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents.

December 1, 2016

Basic Science Research Advisory Committee formed

Vanderbilt University School of Medicine (VUSM) has formed a new Basic Science Research Advisory Committee.

November 10, 2016

Cutting-edge research

Lawrence Marnett, Ph.D., second from right, talks with three Vanderbilt scientists prior to their presentations during last week’s Flexner Discovery Lecture on cutting-edge research. The speakers were, from left, Mark Wallace, Ph.D., Laura Dugan, M.D., and Sachin Patel, M.D., Ph.D.

October 12, 2016

Imaging probe for retinal disease

An imaging probe developed at Vanderbilt detects retinal inflammation early and may allow therapeutic intervention to prevent blindness.

October 6, 2016

Basic science, extraordinary impact

The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. Understanding how these cellular and molecular processes work is the focus of basic biomedical research at Vanderbilt.